Bayer AG has agreed to pay up to $10.9 billion to resolve current and future claims alleging its Roundup weed killer causes cancer.

In an announcement on Wednesday, Bayer said the multiple agreements would resolve 75% of the estimated 125,000 claims over Roundup, which includes those not yet filed in court and case inventories for the leading plaintiffs law firms spearheading the Roundup multidistrict litigation.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]